[The prevalence of antibodies directed against hepatitis C virus in hepatocellular carcinoma: relation to hepatitis B virus, Pugh's score, Okuda's staging and survival].
Giovannini
M
M
Service d'Hépato-gastroentérologie de Nutrition et de Diététique, Hôpital A, Créteil.
Seitz
J F
JF
Pingannaud
M P
MP
Sauvan
R
R
Rossi
I
I
Pasquier
J
J
Gauthier
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000382:microbiology / Q000473:pathology; D005602:France / Q000453:epidemiology; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis*; D006509:Hepatitis B / Q000453:epidemiology*; D006510:Hepatitis B Antibodies / Q000032:analysis*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D008113:Liver Neoplasms / Q000382:microbiology / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D015995:Prevalence
D006508:Hepatitis Antibodies; D006510:Hepatitis B Antibodies
Prévalence des anticorps dirigés contre le virus C dans les carcinomes hépatocellulaires: relation avec le virus B, le score de Pugh, le stade d'Okuda et la survie.